About the Authors
- Outi Vaarala
-
* E-mail: outi.vaarala@helsinki.fi
Affiliation Department of Vaccinations and Immune Protection, National Institute for Health and Welfare, Helsinki, Finland
- Arja Vuorela
-
Affiliation Department of Vaccinations and Immune Protection, National Institute for Health and Welfare, Helsinki, Finland
- Markku Partinen
-
Affiliation Helsinki Sleep Clinic, Vitalmed Research Centre Helsinki and Haartman Institute, University of Helsinki, Helsinki, Finland
- Marc Baumann
-
Affiliation Meilahti Clinical Proteomics Core Facility, Institute of Biomedicine/Biochemistry and Developmental Biology, and NeuroMed Research Program, University of Helsinki, Helsinki, Finland
- Tobias L. Freitag
-
Affiliation Department of Bacteriology and Immunology, Haartman Institute, University of Helsinki, Helsinki, Finland and Research Program Unit, Immunobiology, University of Helsinki, Helsinki, Finland
- Seppo Meri
-
Affiliation Department of Bacteriology and Immunology, Haartman Institute, University of Helsinki, Helsinki, Finland and Research Program Unit, Immunobiology, University of Helsinki, Helsinki, Finland
- Päivi Saavalainen
-
Affiliation Department of Bacteriology and Immunology, Haartman Institute, University of Helsinki, Helsinki, Finland and Research Program Unit, Immunobiology, University of Helsinki, Helsinki, Finland
- Matti Jauhiainen
-
Affiliation National Institute for Health and Welfare, Public Health Genomics Research Unit, Biomedicum, Helsinki, Finland
- Rabah Soliymani
-
Affiliation Meilahti Clinical Proteomics Core Facility, Institute of Biomedicine/Biochemistry and Developmental Biology, and NeuroMed Research Program, University of Helsinki, Helsinki, Finland
- Turkka Kirjavainen
-
Affiliation Department of Pediatrics, Children’s Hospital, Helsinki University Hospital, Helsinki, Finland
- Päivi Olsen
-
Affiliation Department of Child Neurology, Oulu University Hospital, Oulu, Finland
- Outi Saarenpää-Heikkilä
-
Affiliation Department of Pediatrics, Tampere University Hospital, Tampere, Finland
- Juha Rouvinen
-
Affiliation Department of Chemistry and Biocenter Kuopio, University of Eastern Finland, Joensuu, Finland
- Merja Roivainen
-
Affiliation Department of Infectious Disease Surveillance and Control, National Institute for Health and Welfare, Helsinki, Finland
- Hanna Nohynek
-
Affiliation Department of Vaccinations and Immune Protection, National Institute for Health and Welfare, Helsinki, Finland
- Jukka Jokinen
-
Affiliation Department of Vaccinations and Immune Protection, National Institute for Health and Welfare, Helsinki, Finland
- Ilkka Julkunen
-
Affiliations Department of Infectious Disease Surveillance and Control, National Institute for Health and Welfare, Helsinki, Finland, Department of Virology, University of Turku, Turku, Finland
- Terhi Kilpi
-
Affiliation Department of Vaccinations and Immune Protection, National Institute for Health and Welfare, Helsinki, Finland
Competing Interests
HN received honoraria for technical consultancy from GlaxoSmithKline (GSK), and Pfizer for development of pneumococcal conjugate vaccines. JJ is co-investigator of a nationwide effectiveness study of the ten-valent pneumococcal conjugate vaccine mainly funded by GlaxoSmithKline. MP has been consultant for Bioprojet and UCB Pharma and received funding support and honoraries for lecturing from Bioprojet, GSK, Cephalon, and Leiras/Takeda. T. Kilpi is principal investigator of a nationwide effectiveness study of the ten-valent pneumococcal conjugate vaccine mainly funded by GlaxoSmithKline, and her unit received funding for a clinical trial on the safety and immunogenicity of a prototype pandemic influenza vaccine from Solvay Pharmaceuticals. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials. All other authors confirm they have no conflicts of interest. This does not alter the authors’ adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: OV AV MB MJ JR TLF SM. Performed the experiments: OV AV MB MJ TLF IJ MR RS. Analyzed the data: OV AV PS MB MJ TLF JJ. Contributed reagents/materials/analysis tools: MP PO TK OSH. Wrote the paper: OV AV MB MJ JR TLF SM IJ TK HN JJ MP.